Articles dans des revues avec comité de lecture (127)
  1. 10. Carlier, E., Marquette, S., Peerboom, C., Amighi, K., & Goole, J. (2021). Development of mAb-loaded 3D-printed (FDM) implantable devices based on PLGA. International journal of pharmaceutics, 597, 120337. doi:10.1016/j.ijpharm.2021.120337
  2. 11. Wauthoz, N., Rosiere, R., & Amighi, K. (2020). Inhaled cytotoxic chemotherapy: clinical challenges, recent developments, and future prospects. Expert opinion on drug delivery. doi:10.1080/17425247.2021.1829590
  3. 12. Van Der Westhuyzen, A. A., Ingels, A., Rosiere, R., Amighi, K., Oberer, L., Gustafson, K. K., Wang, D., Evidente, A., Maddau, L., Masi, M., De Villiers, A., Green, I. R., Berger, W., Kornienko, A., Mathieu, V., & Van Otterlo, W. W. (2020). Deciphering the chemical instability of sphaeropsidin A under physiological conditions-degradation studies and structural elucidation of the major metabolite. Organic & biomolecular chemistry, 18(40), 8147-8160. doi:10.1039/d0ob01586e
  4. 13. Ronchi, F., Sereno Guerra, A., Paide, M., Hennia, I., Sacré, P.-Y., Guillaume, G., Stéphenne, V., Goole, J., & Amighi, K. (2019). Development and evaluation of budesonide-based modified-release liquid oral dosage forms. Journal of drug delivery science and technology, 54, 101273. doi:10.1016/j.jddst.2019.101273
  5. 14. Rosiere, R., Berghmans, T., De Vuyst, P., Amighi, K., & Wauthoz, N. (2019). The position of inhaled chemotherapy in the care of patients with lung tumours: clinical feasibility and indications according to recent pharmaceutical progresses. Cancers, 11(329), 1-13. doi:10.3390/cancers11030329
  6. 15. Arrighi, A., Marquette, S., Peerboom, C., Denis, L., Goole, J., & Amighi, K. (2019). Development of PLGA microparticles with high immunoglobulin G-loaded levels and sustained-release properties obtained by spray-drying a water-in-oil emulsion. International journal of pharmaceutics, 566, 291-298. doi:10.1016/j.ijpharm.2019.05.070
  7. 16. Salade, L., Wauthoz, N., Goole, J., & Amighi, K. (2019). How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods. International journal of pharmaceutics, 561, 47-65. doi:10.1016/j.ijpharm.2019.02.026
  8. 17. Koubaity, M., Lelubre, M., Sansterre, G., Amighi, K., & De Vriese, C. (2019). Adaptation and validation of PCNE drug-related problem classification v6.2 in French-speaking Belgian community pharmacies. International Journal of Clinical Pharmacy, 41(1), 244-250. doi:10.1007/s11096-018-0773-y
  9. 18. Wauthoz, N., Hennia, I., Ecenarro, S., & Amighi, K. (2018). Impact of capsule type on aerodynamic performance of inhalation products: A case study using a formoterol-lactose binary or ternary blend. International journal of pharmaceutics, 553(1-2), 47-56. doi:10.1016/j.ijpharm.2018.10.034
  10. 19. Wauthoz, N., Hennia, I., Ecenarro, S., & Amighi, K. (2018). Impact of capsule type on aerodynamic performance of inhalation products: A case study using a formoterol-lactose binary or ternary blend. International journal of pharmaceutics, 553(1-2), 47-56. doi:10.1016/j.ijpharm.2018.10.034
  11. 20. Lelubre, M., Clerc, O., Grosjean, M., Amighi, K., De Vriese, C., Bugnon, O., & Schneider, M. P. (2018). Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results. BMC health services research, 18, 874. doi:10.1186/s12913-018-3641-5
  12. 21. Lelubre, M., Clerc, O., Grosjean, M., Amighi, K., De Vriese, C., Bugnon, O., & Schneider, M. P. (2018). Implementation of an interprofessional medication adherence program for HIV patients: description of the process using the framework for the implementation of services in pharmacy. BMC health services research, 18, 698. doi:10.1186/s12913-018-3509-8
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Suivant >>